昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

未开盘 10-14 16:08:26

28.120

-0.440

-1.54%

最高29.200	最低27.640	成交量312.07万
今开28.560	昨收28.560	日振幅5.46%
总市值210.62亿	流通市值33.46亿	总股本7.49亿
成交额8,854万	换手率2.62%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":28.12,"timestamp":1791965306009,"preClose":28.56,"halted":0,"volume":3120674,"delay":0,"changeRate":-0.015406162464985915,"floatShares":118995206,"shares":749000000,"eps":0.4687585351688198,"marketStatus":"未开盘","change":-0.44,"latestTime":"10-14 16:08:26","open":28.56,"high":29.2,"low":27.64,"amount":88536358,"amplitude":0.054622,"askPrice":28.12,"askSize":11400,"bidPrice":28.1,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":1.5641921527304694,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":0,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":28.56,"dividendRate":0.005002,"openAndCloseTimeList":[[1791941400000,1791950400000],[1791954000000,1791964800000]],"volumeRatio":0.500698,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":48.79,"timestamp":1791961200000,"preClose":50.42,"halted":0,"volume":23894300,"delay":0,"premium":"-50.82"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"1155666401","title":"异动解读｜昭衍新药盘中下跌5.68%，港股医药外包板块集体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1155666401","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155666401?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:40","pubTimestamp":1791855624,"startTime":"0","endTime":"0","summary":"10月13日，昭衍新药盘中下跌5.68%，报28.76港元，成交额2012.9万港元。消息面上，港股医药外包及生命科学工具板块整体走弱，金斯瑞生物科技、英矽智能、药明生物等同行同步下挫，行业联动效应显著。尽管公司上半年新签订单同比增长98.0%、在手订单同比增长60.9%，且华泰证券维持A、H股买入评级，但短期外资机构调仓及板块性抛压仍主导盘面。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昭衍新药盘中下挫，医药外包板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675385097","title":"昭衍新药(06127)转仓市值总计2.02亿港元 占比5.43% 从香港上海汇丰银行转出315.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675385097","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675385097?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:10","pubTimestamp":1791850253,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，10月12日，昭衍新药(06127)出现仓位异动，转仓市值总计2.02亿港元，占比5.43%。该公司股东向摩根士丹利香港证券转入302.68万股，从香港上海汇丰银行转出315.73万股。华泰证券此前指出，公司上半年整体在手订单金额约37亿元，同比增长60.9%，新签订单金额约20.2亿元，同比增长98.0%，其中2Q26新签订单金额约11.1亿元，订单表现持续亮眼，后续业绩能见度进一步提升。考虑国内行业需求积极回暖，叠加公司海外业务持续拓展，看好公司业务中长期成长空间。公司A、H股均维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU0976567544.SGD","LU0516423174.USD","LU0918141705.HKD","HSBC","LU1770036033.HKD","LU0516422440.USD","BK1231","BK4207","LU0164880469.USD","LU2226246903.HKD","BK1576","HSHD.SI","LU0211326755.USD","LU1267930227.SGD","LU1481107354.HKD","603127","LU0128525689.USD","LU2449936058.SGD","LU0348735423.USD","BK1601","LU0516422366.SGD","HSBA.UK","BK1141","BK4521","LU0634319403.HKD","LU1105468828.SGD","03143","06127","LU0417516738.SGD","LU0516423091.SGD","LU0149721374.USD","BK4588","LU0516422952.EUR","LU1282648689.USD","00005","LU0345776255.USD","BK4585","BK1572","LU0345775950.USD","LU0496365809.HKD","IE0008369823.USD","LU0797268264.HKD","LU0052756011.USD","LU0540923850.HKD","BK1610","BK0216","HSBH","LU0310800965.SGD","LU0348814723.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675801792","title":"股市必读：昭衍新药（603127）10月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675801792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675801792?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:15","pubTimestamp":1791825317,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，昭衍新药报收于50.73元，下跌3.56%，换手率6.98%，成交量43.82万手，成交额22.96亿元。董秘最新回复投资者： 董秘好，能发布一下最近的股东人数吗？请将个人持股证明等文件发送到公司联系邮箱，或者致电010-67869582，公司核实后进行回复，谢谢。当日关注点交易信息汇总：10月12日主力资金净流出1044.88万元，占总成交额0.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","BK0216","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674812812","title":"一个月内股价上涨超40%，昭衍新药(06127)H股何以走出弹性更强的独立行情？","url":"https://stock-news.laohu8.com/highlight/detail?id=2674812812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674812812?lang=zh_cn&edition=full","pubTime":"2026-10-11 16:58","pubTimestamp":1791709113,"startTime":"0","endTime":"0","summary":"8月28日盘后，昭衍新药发布26H1业绩快报。然而，当昭衍新药在9月29日正式披露26H1财报后，其H股股价却在次日大幅收涨15.62%。从盘面来看，8月10日至9月11日，昭衍新药H股收盘价从26.64港元跌至21.20港元，区间累计跌幅为20.42%。值得一提的是，在9月14日以来的这轮行情中，昭衍新药的H股显示出了更强的弹性。而这在一定程度说明昭衍新药的A股与板块情绪存在联动，但其H股超额收益明显，显示出更强的独立定价特征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","06127","BK0216","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119183504","title":"昭衍新药：摩根士丹利减持，好仓比例降至4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119183504","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119183504?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:23","pubTimestamp":1791537828,"startTime":"0","endTime":"0","summary":"2026年10月6日，摩根士丹利以每股均价31.7780港元出售昭衍新药（06127）147.35万股H股，涉资约4682.62万港元。该笔交易属场外交易，并非在联交所公开市场直接买卖。摩根士丹利此次减持前持有昭衍新药好仓706.76万股，占比5.93%；减持后持股量为559.41万股，好仓比例降至4.70%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674783058","title":"摩根士丹利在昭衍新药的H股好仓比例下降1.23%至4.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674783058","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674783058?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:19","pubTimestamp":1791537540,"startTime":"0","endTime":"0","summary":"南财智讯10月9日电，香港交易所披露信息显示，MorganStanley（摩根士丹利）在昭衍新药的H股好仓（L）比例于10月6日从5.93%下降至4.70%。同时淡仓（S）比例从0.94%降至0.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093891327295.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093891327295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","06127","BK1141","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150900962","title":"异动解读｜昭衍新药盘中下跌5.59%，医药板块集体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1150900962","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150900962?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:39","pubTimestamp":1791509983,"startTime":"0","endTime":"0","summary":"10月9日，昭衍新药盘中下跌5.59%，报28.44港元，成交额2135.0万港元。消息面上，港股医药及CRO板块今日整体走弱，药明生物跌3.97%、药明合联跌4.56%、英矽智能跌2.78%、药明康德跌2.58%，行业联动效应显著。此前隔夜美股医药板块暴跌，莫德纳遭花旗下调评级并大幅削减目标价，情绪跨市场传导拖累港股CRO及创新药赛道。尽管昭衍新药上半年新签订单同比增长98%、在手订单同比增长60.9%，且近期获摩根士丹利增持H股，但短期板块性抛压仍主导盘面走势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昭衍新药盘中下跌，医药板块集体承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674867978","title":"昭衍新药（603127）10月8日主力资金净买入1.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674867978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674867978?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:15","pubTimestamp":1791504957,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，昭衍新药报收于52.06元，上涨5.6%，换手率13.31%，成交量83.58万手，成交额43.1亿元。10月8日的资金流向数据方面，主力资金净流入1.37亿元，占总成交额3.18%，游资资金净流入7938.25万元，占总成交额1.84%，散户资金净流出2.16亿元，占总成交额5.02%。融券方面，融券卖出8.26万股，融券偿还1.23万股，融券余量25.01万股，融券余额1302.02万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900005881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","06127","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027860","title":"10月8日昭衍新药涨5.60%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027860?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:33","pubTimestamp":1791448436,"startTime":"0","endTime":"0","summary":"证券之星消息，10月8日昭衍新药涨5.60%，收盘报52.06元，换手率13.31%，成交量83.58万手，成交额43.1亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共39家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.8912，较上一交易日上涨2.55%，近一年下跌9.72%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK1576","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673284830","title":"昭衍新药午后涨逾4% 华泰证券维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2673284830","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673284830?lang=zh_cn&edition=full","pubTime":"2026-10-08 13:10","pubTimestamp":1791436200,"startTime":"0","endTime":"0","summary":"模拟交易客户端昭衍新药盘中逆势涨超5%，截至发稿，股价上涨3.93%，现报30.66港元，成交额2.09亿港元。华泰证券此前指出，公司上半年整体在手订单金额约37亿元，同比增长60.9%，新签订单金额约20.2亿元，同比增长98.0%，其中2Q26新签订单金额约11.1亿元，订单表现持续亮眼，后续业绩能见度进一步提升。公司A、H股均维持“买入”评级。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-08/doc-iniunvxc7578225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673040800","title":"港股异动 | 昭衍新药(06127.HK)逆势涨超5% 机构看好公司业务中长期成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2673040800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673040800?lang=zh_cn&edition=full","pubTime":"2026-10-08 11:58","pubTimestamp":1791431894,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164693782","title":"异动解读｜昭衍新药盘中上涨5.36%，CRO板块回暖叠加机构增持提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1164693782","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164693782?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:55","pubTimestamp":1791424500,"startTime":"0","endTime":"0","summary":"10月8日，昭衍新药盘中上涨5.36%，报31.04港元，成交额6406.21万港元。消息面上，CRO板块整体走强，昭衍新药此前获摩根士丹利于9月29日增持H股约45.7万股，好仓比例升至5.23%，对市场情绪形成一定支撑。公司2026年上半年实现营收7.04亿元，同比增长5.27%；经调整净利润7.48亿元，同比大增1126.80%；新签订单约20.2亿元，同比增长98.0%，在手订单约37亿元，同比增长60.9%。机构持仓变动叠加行业景气度回升，成为盘中股价上行的重要背景。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药异动拉升，CRO回暖叠加机构增持","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145357150","title":"昭衍新药更新2026年9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1145357150","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145357150?lang=zh_cn&edition=full","pubTime":"2026-10-07 15:21","pubTimestamp":1791357699,"startTime":"0","endTime":"0","summary":"北京昭衍新药研究中心股份有限公司于2026年10月7日披露截至2026年9月30日的月度证券变动情况。公告显示，公司本月无新增发行或股份变动，整体股本维持不变。根据披露，普通股包括H股和A股两类：H股期末已发行股数为118,995,206股，A股期末已发行股数为630,353,014股。其中，A股无流通股变动，且当月未发生公司股份回购及注销行为。A股在当期仍保留537,620股库存股未发生变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673642890","title":"港股异动 | 医药板块全线重挫 金斯瑞生物科技(01548.HK)跌超15% 昭衍新药(06127.HK)跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673642890","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673642890?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:57","pubTimestamp":1791338244,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000320264.USD","HK0000306685.HKD","06127","HK0000306701.USD","BK1576","BK1515","BK1583","HK0000320223.HKD","BK1161","BK1141","01548","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190144897","title":"港股直击｜医药股及医药外包股重挫，金斯瑞生物科技大跌 14%，康希诺生物、歌礼制药跌 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190144897","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190144897?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:38","pubTimestamp":1791337108,"startTime":"0","endTime":"0","summary":"医药股及医药外包股重挫，金斯瑞生物科技大跌 14%，昭衍新药跌 10%，康希诺生物、歌礼制药、再鼎医药、和铂医药跌 6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","06185","01548","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149518442","title":"异动解读｜昭衍新药盘中下跌9.57%，CRO板块集体走弱拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1149518442","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149518442?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:31","pubTimestamp":1791336691,"startTime":"0","endTime":"0","summary":"10月7日，昭衍新药盘中下跌9.57%，报29.12港元，成交额120.9万港元。消息面上，CRO概念股整体承压，金斯瑞生物科技大跌16.04%，英矽智能跌5.31%，晶泰控股跌4.64%，药明生物跌2.85%，药明康德跌1.10%，行业板块联动效应显著。此前摩根士丹利于9月29日增持昭衍新药H股约45.7万股，好仓比例升至5.23%；广发基金亦曾于9月24日增持40.92万股后于9月28日减持37.74万股，机构持仓变动频繁，加剧短期波动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昭衍新药盘中大跌，CRO板块集体走弱拖累","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100327969","title":"异动解读｜昭衍新药盘中上涨5.09%，机构增持与CRO板块景气共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1100327969","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100327969?lang=zh_cn&edition=full","pubTime":"2026-10-06 13:32","pubTimestamp":1791264778,"startTime":"0","endTime":"0","summary":"10月6日，昭衍新药盘中上涨5.09%，报32.2港元，成交额2703.67万港元。消息面上，港交所披露显示摩根士丹利于9月29日在昭衍新药H股的好仓比例由4.84%升至5.23%，增持约45.7万股，每股作价约26.52港元；此前广发基金亦于9月24日增持40.92万股，好仓比例一度升至5.14%。机构密集加仓叠加CRO板块景气上行，对股价形成支撑。公司2026年上半年营收7.04亿元，同比增长5.27%，经调整净利润7.48亿元，同比大增1126.80%，新签订单约20.2亿元，同比增长98.0%，在手订单约37亿元，同比增长60.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"机构加仓昭衍新药，CRO景气推升股价","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673701795","title":"Morgan Stanley增持昭衍新药(06127.HK)约45.7万股 每股作价约26.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673701795","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673701795?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:43","pubTimestamp":1791197011,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06127","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673701356","title":"摩根士丹利在昭衍新药的H股好仓比例上升0.39%至5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673701356","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673701356?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:04","pubTimestamp":1791194662,"startTime":"0","endTime":"0","summary":"南财智讯10月5日电，香港交易所披露信息显示，MorganStanley（摩根士丹利）在昭衍新药的H股好仓（L）比例于9月29日从4.84%上升至5.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610053888651587.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610053888651587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1576","BK0216","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220970","title":"智通港股解盘 | 政策利好地产出现分化 医药板块再度成为避风港","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220970","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671220970?lang=zh_cn&edition=full","pubTime":"2026-09-30 19:50","pubTimestamp":1790769039,"startTime":"0","endTime":"0","summary":"另外，与科技巨头签自愿性AI安全协议，并力挺数据中心扩张。OpenAI投资的生物安全初创公司Red Queen Bio累计融资3600万美元，用于研发可对抗多种病毒的抗体药物，并计划于2027年启动首批临床试验。该机构认为，航空货运运价同比维持较高增速，景气仍具韧性，客运端关注国庆假期量价兑现。迈富时募资持续加码算力基建，部分城市Token券补贴有望进一步缩短投资回收期。迈富时加速落地外贸AI智能体，利润爆发增长表现亮眼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01276","01081","BK1141","BK1191","LU0359201885.HKD","KCAI","BK1515","BK1576","BK1505","LU0359202008.SGD","BK1205","BK1514","BK1618","LU2543165471.USD","BK1561","159938","BK1123","06127","09939","BK4585","LU0359201612.USD","VXUS","00753","02556","BK1161","BK1518","BK1109","BK1574","BK4588","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":0.2587},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.2896},{"period":"1year","weight":0.4778},{"period":"ytd","weight":0.3759}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052852},{"month":2,"riseRate":0.6,"avgChangeRate":0.086368},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020373},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07562},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065576},{"month":6,"riseRate":0.666667,"avgChangeRate":0.063039},{"month":7,"riseRate":0.833333,"avgChangeRate":0.119134},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.109974},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056709},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.066972},{"month":11,"riseRate":0.4,"avgChangeRate":0.019565},{"month":12,"riseRate":0.6,"avgChangeRate":0.001933}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}